Effects of omadacycline: A Synthesis of Findings from 20 Studies
- Home
- Effects of omadacycline
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of omadacycline: A Synthesis of Findings from 20 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main research findings
Omadacycline is a new aminomethylcycline antibiotic with a broad spectrum of activity against various bacterial species, including Gram-positive, Gram-negative, anaerobic, and atypical bacterial pathogens. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 It is available as a once-daily intravenous or bioequivalent oral formulation, making it a convenient option for patients. 2 、 6 Omadacycline has shown promising results in treating infections caused by Mycobacterium abscessus. 10 、 11 Additionally, it has been found to have low potential for causing Clostridioides difficile infection and is considered a safe option for cardiovascular health. 16 、 1 、 3 However, it is important to note that omadacycline might have some impact on bone metabolism. 18
Benefits and Risks
Benefit Summary
Omadacycline provides a broad spectrum of activity against various bacterial species, offering a potential solution for multidrug-resistant infections. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 The once-daily dosage regimen simplifies treatment for patients, reducing the burden of frequent medication administration. 2 、 6 Omadacycline is considered a promising option for treating infections caused by Mycobacterium abscessus. 10 、 11 Additionally, its low propensity to cause Clostridioides difficile infection and favorable cardiovascular safety profile make it a potentially advantageous choice for certain patients. 16 、 1 、 3
Risk Summary
Omadacycline might have an impact on bone metabolism, warranting caution, especially for pregnant and breastfeeding women. 18 Similar to other antibiotics, omadacycline can cause adverse effects such as allergic reactions and gastrointestinal issues. 6
Comparison of Studies
Similarities
Multiple studies demonstrate omadacycline’s effectiveness against a broad spectrum of bacteria. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 Many studies highlight the convenient once-daily administration, reducing the burden for patients. 2 、 6
Differences
The methods used to assess omadacycline’s efficacy and safety vary across studies. For example, some research focuses on its effectiveness against Mycobacterium abscessus infections, while others examine its impact on the cardiovascular system. 10 、 11 、 3 Additionally, the patient population and study designs differ, requiring cautious interpretation of the results.
Consistency and Contradictions
Omadacycline has demonstrated consistent effectiveness against a broad spectrum of bacterial species in numerous studies. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 Research also supports its favorable cardiovascular safety profile. 3 However, its potential impact on bone metabolism needs further investigation, particularly for pregnant and breastfeeding women. 18
Practical Considerations
While omadacycline shows promise against a broad range of bacteria, it is not effective against all infections. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 Like other antibiotics, omadacycline can cause adverse effects such as allergic reactions and gastrointestinal problems. 6 Pregnant and breastfeeding women should consult their healthcare provider before using omadacycline. 18
Limitations of Current Research
Research on omadacycline is still ongoing, and more studies are needed to fully understand its long-term safety and efficacy. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 Further research is needed to thoroughly understand its potential impact on bone metabolism. 18
Future Research Directions
Long-term studies are necessary to evaluate the safety and efficacy of omadacycline. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 Further investigation is crucial to understand omadacycline’s impact on bone metabolism. 18
Conclusion
Omadacycline is a promising new antibiotic with a wide spectrum of activity against various bacteria. 6 、 10 、 7 、 17 、 13 、 9 、 4 、 5 、 20 、 2 、 15 、 16 、 19 、 11 、 8 、 3 、 1 、 12 、 18 It offers the convenience of once-daily administration, reducing the burden for patients. 2 、 6 However, its potential impact on bone metabolism needs careful consideration, especially for pregnant and breastfeeding women. 18 It is important to consult with a healthcare professional regarding omadacycline usage and follow their guidance.
Benefit Keywords
Risk Keywords
Article Type
Author: JoJinhee, HuChenlin, BegumKhurshida, WangWeiqun, LeThanh M, AgyapongSamantha, HansonBlake M, AyeleHossaena, LancasterChris, AlamM Jahangir, Gonzales-LunaAnne J, GareyKevin W
Language : English
Author: DarpoBorje, XueHongqi, TanakaS Ken, TzanisEvan
Language : English
Author: TanakaS Ken, VillanoStephen
Language : English
Author: XuLimin, FangChangquan
Language : English
Author: El GhaliAmer, MorrisetteTaylor, AlosaimySara, LucasKristen, Tupayachi-OrtizMaria G, VemulaRaaga, WadleCarly, PhilleyJulie V, Mejia-ChewCarlos, HamadYasir, StevensRyan W, ZeuliJohn D, WebbAndrew J, FiskeChristina T, SimonyanAnahit, CiminoChristo L, MammadovaMehriban, UmanaVirginia E, HasbunRodrigo, ButtSaira, MolinaKyle C, ThomasMichael, KaipEmily A, BouchardJeannette, GoreTristan W, HowardCatessa, CabanillaM Gabriela, HolgerDana J, FrensJeremy J, BargerMelissa, OngAaron, CohenKeira A, RybakMichael J
Language : English
Author: RodriguezGeorge D, WarrenNathan, YashayevRoman, ChitraSurya, Amodio-GrotonMaria, WrightKelly
Language : English
Omadacycline for treatment of acute bacterial infections: a meta-analysis of phase II/III trials.
Author: LinFei, HeRong, YuBin, DengBowen, LingBaodong, YuanMingyong
Language : English
Author: IngramPaul R, JonesEva E, AllenBethwyn, MurrayRonan J, KeehnerTerillee J, WhitmoreTimothy J
Language : English
Author: WenLi-Li, KuoPei-Yun, ThuyTran Thi Dieu, DuongTran Thi Thuy, HuangYu-Tsung, HsuehPo-Ren, ChenYu-Chen, KaoCheng-Yen
Language : English
Author: ZhangTingting, DuJian, DongLingling, WangFen, ZhaoLiping, JiaJunnan, WangCongli, ChengMengli, YuXia, HuangHairong
Language : English
Author: RizzoAshley R, MoniriNader H
Language : English
Author: BryantAmy E, StevensDennis L
Language : English
Author: NiakaniSepehr, LiuHattie, LiuWen-Ying, HornerRichard L
Language : English
Author: LiHuijuan, LiangXueyan, MoGuangyan, GuoSitong, ChenXiaoyu, LiYan
Language : English
Author: LaPlanteKerry L, DhandAbhay, WrightKelly, LauterioMelanie
Language : English
Author: GareyKevin W, RoseWarren, GunterKyle, SerioAlisa W, WilcoxMark H
Language : English
Author: MorrisetteTaylor, AlosaimySara, LagnfAbdalhamid M, FrensJeremy J, WebbAndrew J, VeveMichael P, StevensRyan, BouchardJeannette, GoreTristan W, AnsariIman, RybakMichael J
Language : English
Author: WarnerAmy J, Hathaway-SchraderJessica D, LubkerRena, DaviesChristopher, NovinceChad M
Language : English
Author: HanRenru, DingLi, YangYang, GuoYan, YinDandan, WuShi, ZhiPeiyuan, ZhuDemei, LiuQingmei, TanXiaojuan, ZhuYuanju, ZhangJay, LiLi, HuFupin
Language : English
Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment.
Author: LeeYu-Lin, ChenHsien-Meng, HiiIng-Moi, HsuehPo-Ren
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.